Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Genomic Endometrial Expression in Obesity

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00505986
Recruitment Status : Completed
First Posted : July 25, 2007
Last Update Posted : April 2, 2012
Sponsor:
Information provided by (Responsible Party):
Jose Bellver, Instituto Valenciano de Infertilidad, IVI VALENCIA

Brief Summary:
Determine if different genomic endometrial expression exists during embryo implantation in obese women in comparison with non obese women.

Condition or disease Intervention/treatment Phase
Obesity and Embryo Implantation Procedure: endometrial biopsy Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Study Start Date : June 2007
Actual Primary Completion Date : May 2009
Actual Study Completion Date : May 2009




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 35 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • group A: non obese oocyte donors (BMI: 18 - 29 kg. /m2)with proven fertility
  • group B: obese oocyte donors: (BMI: >29 kg./m2)with proven fertility
  • group C: obese (BMI: >29 kg./m2) infertile patients,

Exclusion Criteria:

  • recurrent miscarriage

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00505986


Locations
Layout table for location information
Spain
Instituto Valenciano de Infertilidad Spain
Valencia, Spain, 46015
Sponsors and Collaborators
Instituto Valenciano de Infertilidad, IVI VALENCIA
Investigators
Layout table for investigator information
Principal Investigator: Jose Bellver, MD PhD Instituto Valenciano de Infertilidad
Layout table for additonal information
Responsible Party: Jose Bellver, Gynecologist IVI Valencia, Instituto Valenciano de Infertilidad, IVI VALENCIA
ClinicalTrials.gov Identifier: NCT00505986    
Other Study ID Numbers: VLC-JB-0507-607-29
First Posted: July 25, 2007    Key Record Dates
Last Update Posted: April 2, 2012
Last Verified: March 2012
Additional relevant MeSH terms:
Layout table for MeSH terms
Obesity
Overnutrition
Nutrition Disorders
Overweight
Body Weight
Signs and Symptoms